Kits for fully automated testing

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of alpha-fetoprotein (AFP) in serum or plasma. The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the fully automated quantitative measurement of AMH in specimens based a two-step immunoassay method on the LUMIPULSE G System.

The Lumipulse G B•R•A•H•M•S PCT assay is for use on the LUMIPULSE G system (with chemiluminescent enzyme immunoassay (CLEIA) technology) for the quantitative determination of procalcitonin (PCT) in human serum and plasma.

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA125 in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of CA19-9-N in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of the MB iso-enzyme of the creatine kinase (CK-MB) in human serum or plasma. This product is for professional use only.

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G System for the quantitative measurement of estradiol (E2) in serum and plasma.

Immunoreaction cartridges for for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of free prostate specific antigen (free PSA) in human serum or plasma.

For in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of free triiodothyronine (FT3) in serum or plasma. This assay uses a mouse monoclonal antibody.

Immunoreaction cartridges set for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the qualitative detection of IgM antibody to hepatitis B core antigen (anti-HBc IgM) in human serum or plasma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the qualitative detection of antibody to hepatitis B e antigen (anti-HBe) in human serum or plasma. This product is indicated as an aid in the diagnosis and monitoring of hepatitis B viral infection and for professional use only.

Immunoreaction cartridges for in vitro diagnostics (IVD) use with the LUMIPULSE G System for the qualitative and quantitative detection of hepatitis B surface antigen (HBsAg) in human serum or plasma.

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative measurement of high-molecular-weight adiponectin (HMW Adiponectin) in serum or plasma.based on CLEIA technology by two-step sandwich immunoassay method on the LUMIPULSE G system and with results that are available in up to 30 minutes.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for qualitative detection of antibody to HTLV-I and HTLV-II in human serum or plasma for screening of HTLV-I/II viral infection.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of insulin in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of luteinizing hormone (LH) in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of myoglobin in human serum or plasma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of pepsinogen Ⅱ in specimens based on CLEIA technology by two-step sandwich immunoassay on the LUMIPULSE G system.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of Progesterone in serum or plasma. The assay utilises proven CLEIA (ChemiLuminescent Enzyme Immunoassay) technology with results that are available in up to 35 minutes.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of prolactin in serum or plasma.

For in vitro diagnostic (IVD) use as quality controls, to monitor the precision and accuracy of the Lumipulse G SARS-CoV-2 N-IgG assay on the automated LUMIPULSE G System.

Immunoreaction cartridges for in vitro diagnostic use with the LUMIPULSE G instruments for the quantitative measurement of squamous cell carcinoma (SCC) antigen in human serum or plasma samples as an aid in the management of patients with squamous cell carcinoma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of thyroxine (T4) in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of anti-thyroglobulin antibodies (TgAb) in serum or plasma.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the qualitative measurement of treponema pallidum (TP) antibodies (IgG and IgM) in serum or plasma. Includes calibrators.

Immunoreaction cartridges for in vitro diagnostic (IVD) use with the LUMIPULSE G System for the quantitative measurement of thyroid-stimulating hormone (TSH) in serum or plasma.

For in vitro diagnostics (IVD) use with the LUMIPULSE G System for the quantitative measurement of ß2-microglobulin (ß2m) in serum, plasma and urine.